Impact of positron emission tomography on the initial staging and therapy in locoregional advanced squamous cell carcinoma of the head and neck

Laryngoscope

Volumn 113, Issue 5, 2003, Pages 888-891

  Schmid, Daniel T ^a   Stoeckli, Sandro J ^a   Bandhauer, Florian ^a   Huguenin, Pia ^a   Schmid, Stephan ^a   Von Schulthess, Gustav K ^a   Goerres, Gerhard W ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Head and neck cancer; Metastasis; Positron emission tomography; Staging; Synchronous cancer

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER CYTODIAGNOSIS; CANCER STAGING; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; HEAD CANCER; HUMAN; INFLAMMATION; LYMPH NODE METASTASIS; MALE; METASTASIS; NECK CANCER; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; THORAX RADIOGRAPHY; TREATMENT PLANNING; X RAY FILM;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEASIBILITY STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, SPIRAL COMPUTED;

EID: 0037627658     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200305000-00021     Document Type: Article

References (18)

1. Minn H, Paul R, Ahonen A. Evaluation of treatment response to radiotherapy in head and neck cancer with fluorine-18 fluorodeoxyglucose. J Nucl Med 1988;29:1521-1525.
2. Reisser C, Eichhorn K, Herold-Mende C. Glucose uptake in malignant tumors of the head and neck. HNO 1999;47:712-717.
3. Kau RJ, Alexiou C, Laubenbacher C, Werner M, Schwaiger M, Arnold W. Lymph node detection of head and neck squamous cell carcinomas by positron emission tomography with fluorodeoxyglucose F 18 in a routine clinical setting. Arch Otolaryngol Head Neck Surg 1999;125:1322-1328.
4. Reske SN, Kotzerke J. FDG-PET for clinical use: results of the Third German Interdisciplinary Consensus Conference, 'Onko-PET III,' 21 July and 19 September 2000. Eur J Nucl Med 2001;28:1707-1723.
5. Adams S, Baum RP, Stuckensen T, Bitter K, Hor G. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med 1998;25:1255-1260.
6. McGuirt WF, Williams DW III, Keyes JW Jr, et al. A comparative diagnostic study of head and neck nodal metastases using positron emission tomography. Laryngoscope 1995;105:373-375.
7. Bailet JW, Abemayor E, Jabour BA, Hawkins RA, Ho C, Ward PH. Positron emission tomography: a new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy. Laryngoscope 1992;102:281-288.
8. Stokkel MP, Moons KG, ten Broek FW, van Rijk PP, Hordijk GJ. 18F-fluorodeoxyglucose. dual-head positron emission tomography as a procedure for detecting simultaneous primary tumors in cases of head and neck cancer. Cancer 1999;86:2370-2377.
9. Minn H, Lapela M, Klemi PJ, et al. Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer. J Nucl Med 1997;38:1907-1911.
10. Million RR, Cassisi NJ, Clark JR. Cancer of the head and neck. In: DeVita VTJ, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. Philadelphia: JB Lippincott, 1989:488-590.
11. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and neck cancer. N Engl J Med 1993;328:184-194.
12. Stoeckli SJ, Zimmermann R, Schmid S. Role of routine panendoscopy in cancer of the upper aerodigestive tract. Otolaryngol Head Neck Surg 2001;124:208-212.
13. Union Internationale Contre le Cancer. TNM Atlas. New York, Berlin, Heidelberg: Springer-Verlag, 1997.
14. Burger C, Goerres G, Schoenes S, Buck A, Lonn AHR, von Schulthess GK. PET Attenuation coefficients from CT images: experimental evaluation of the transformation of CT into PET 511 keV attenuation coefficients. Eur J Nucl Med 2002;29:922-927.
15. Kunkel M, Grotz KA, Forster GJ, et al. Therapy monitoring with 2-(18F)-FDG positron emission tomography after neo-adjuvant radiation treatment of mouth carcinoma. Strahlenther Onkol 2001;177:145-152.
16. Quesada JL, Alealde JM, Garcia-Velloso MJ, Cervera-Paz FJ, Garcia-Tapia R. Positron-emission tomography (PET) in the diagnosis of malignancy, recurrence, and staging in patients with head and neck tumors. Acta Otorrinolaringol Esp 2000;51:629-633.
17. Di Martino E, Nowak B, Hassan HA, et al. Diagnosis and staging of head and neck cancer: a comparison of modern imaging modalities (positron emission tomography, computed tomography, color-coded duplex sonography) with panendoscopic and histopathologic findings. Arch Otolaryngol Head Neck Surg 2000;126:1457-1461.
18. Ak I, Stokkel MP, Pauwels EK. Positron emission tomography with 2-[18F] fluoro-2-deoxy-D-glucose in oncology, II: the clinical value in detecting and staging primary tumours. J Cancer Res Clin Oncol 2000;126:560-574.